WPI 3497 (Galantamine hydrobromide extended release 16 mg)
Pill imprint WPI 3497 has been identified as Galantamine hydrobromide extended release 16 mg.
Galantamine is used in the treatment of alzheimer's disease and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Galantamine 16 mg is not a controlled substance under the Controlled Substance Act (CSA).
Galantamine hydrobromide extended release
- Imprint:
- WPI 3497
- Strength:
- 16 mg
- Color:
- Pink & White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-3497
- Inactive Ingredients:
- gelatin
hydroxypropyl cellulose
magnesium stearate
silicon dioxide
titanium dioxide
ferric oxide red
More about galantamine
Consumer resources
- Other brands: Razadyne, Razadyne ER
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
